TP53 and cancer: The first experiments demonstrated that MDM2 inhibitors cause cell cycle arrest and apoptosis in wild-type p53 cancer cells, whereas only transient cell cycle arrest and minimal accumulation of p53 with low cytotoxic effects were observed in normal cells in animal models [39, 77].